Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2019 Filed Apr 9, 2019 00:30 UTC |
Perone Thomas MichaelSVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001209191-19-024055 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-03-24 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 16:42 UTC |
During MatthewDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-19-023196 · doc4.xml · derivative · entry 1 During Matthew · CIK 0001704631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-03-31 F1 · derivative.exercise_date: 25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:43 UTC |
Rakhit AmitCMO and PMO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-19-023200 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · CMO and PMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-03-31 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on April 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:15 UTC |
Bernstein KarenDirector
|
PurchaseCommon Stock | 10,000 | $2.02 | $20,210.00 |
DisclosureSEC source: 0001209191-19-014804 · doc4.xml · nonDerivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to 2.08 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4. Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 21:42 UTC |
During MatthewDirector · President and CSO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013904 · doc4.xml · derivative · entry 1 During Matthew · CIK 0001704631 · Director · President and CSO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-02-23 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 21:43 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013906 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-02-23 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 02:42 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013905 · doc4.xml · derivative · entry 4 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-02-23 F3 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 21:54 UTC |
Daly TimothySVP,Finance & Corp. Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013908 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · SVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-02-23 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 02:44 UTC |
Ward AnaSVP and General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013907 · doc4.xml · derivative · entry 1 Ward Ana · CIK 0001716354 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-02-23 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 02:56 UTC |
Rakhit AmitCMO and PMO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-19-013909 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · CMO and PMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-02-23 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 02:42 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
PurchaseCommon Stock | 75,000 | $2.00 | $150,000.00 |
DisclosureSEC source: 0001209191-19-013905 · doc4.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,676,529 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 18:24 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0001209191-18-048858 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2028-08-27 F1 · derivative.exercise_date: The option, representing a right to purchase a total of 22,500 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 18:27 UTC |
Daly TimothySVP,Finance & Corp. Controller
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0001209191-18-048860 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · SVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2028-08-27 F1 · derivative.exercise_date: The option, representing a right to purchase a total of 11,250 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 22:28 UTC |
Ward AnaSVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0001209191-18-048861 · doc4.xml · derivative · entry 1 Ward Ana · CIK 0001716354 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2028-08-27 F1 · derivative.exercise_date: The option, representing a right to purchase a total of 11,250 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 22:26 UTC |
Rakhit AmitCMO and PMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0001209191-18-048859 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · CMO and PMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-08-27 F1 · derivative.exercise_date: The option, representing a right to purchase a total of 70,000 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 21:22 UTC |
WILLIAMS DOUGLAS EDirector
|
PurchaseCommon Stock | 5,000 | $6.49 | $32,441.50 |
DisclosureSEC source: 0001209191-18-047229 · doc4.xml · nonDerivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.43 to $6.50 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4. Read SEC document |
| August 14, 2018 Filed Aug 17, 2018 01:24 UTC |
Bernstein KarenDirector
|
PurchaseCommon Stock | 10,000 | $6.23 | $62,300.00 |
DisclosureSEC source: 0001209191-18-047230 · doc4.xml · nonDerivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.005 to $6.5467 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 21:41 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001209191-18-036748 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 17:45 UTC |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001209191-18-036753 · doc4.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 21:43 UTC |
Friedman BartDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001209191-18-036751 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 21:40 UTC |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001209191-18-036747 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 16:47 UTC |
Werber YaronCBO, CFO, Sec. and Treas.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 131,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004916 · doc4.xml · derivative · entry 1 Werber Yaron · CIK 0001704638 · CBO, CFO, Sec. and Treas. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,000 Underlying: Common Stock · 131,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 16:39 UTC |
During MatthewDirector · President and CSO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004905 · doc4.xml · derivative · entry 1 During Matthew · CIK 0001704631 · Director · President and CSO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 16:40 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004909 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:41 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 290,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004911 · doc4.xml · derivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,000 Underlying: Common Stock · 290,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 16:37 UTC |
Daly TimothySVP,Finance & Corp. Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004900 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · SVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:45 UTC |
Ward AnaSVP and General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004913 · doc4.xml · derivative · entry 1 Ward Ana · CIK 0001716354 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:43 UTC |
Rakhit AmitCMO and PMO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-18-004912 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · CMO and PMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-01-18 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 22:23 UTC |
Ward AnaSVP and General Counsel
|
GrantStock Option Grant (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001209191-17-051748 · doc4.xml · derivative · entry 1 Ward Ana · CIK 0001716354 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2027-09-04 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on September 1, 2018 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 22:29 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
PurchaseCommon Stock | 15,334 | $7.15 | $109,638.10 |
DisclosureSEC source: 0001209191-17-050467 · doc4.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,601,529 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.65 to $7.33 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:51 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,627 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001209191-17-040239 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,627 Underlying: Common Stock · 11,627 shares Expires 2027-06-13 F1 · derivative.exercise_date: The option shall vest as follows: 1/36th of the shares subject to the option shall vest every month after June 14, 2017, such that the option will have vested in full on June 14, 2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) on each vesting date. Read SEC document |
| May 10, 2017 Filed May 10, 2017 17:17 UTC |
Werber YaronCBO, CFO, Sec. and Treas.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 93,022 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001209191-17-031377 · doc4.xml · derivative · entry 1 Werber Yaron · CIK 0001704638 · CBO, CFO, Sec. and Treas. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,022 Underlying: Common Stock · 93,022 shares Expires 2027-01-19 F1 · derivative.exercise_date: 100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms. Read SEC document |
| May 10, 2017 Filed May 10, 2017 17:14 UTC |
During MatthewDirector · President and CSO · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 28,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031374 · doc4.xml · derivative · entry 6 During Matthew · CIK 0001704631 · Director · President and CSO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,245 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. Read SEC document |
| May 10, 2017 Filed May 10, 2017 17:14 UTC |
During MatthewDirector · President and CSO · 10% owner
|
ConversionCommon Stock | 28,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-031374 · doc4.xml · nonDerivative · entry 1 During Matthew · CIK 0001704631 · Director · President and CSO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,307,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. Read SEC document |
| May 10, 2017 Filed May 10, 2017 21:16 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 35,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031376 · doc4.xml · derivative · entry 5 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 35,461 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse in the manager of Divo. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| May 10, 2017 Filed May 10, 2017 21:16 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 400,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031376 · doc4.xml · derivative · entry 4 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. Read SEC document |
| May 10, 2017 Filed May 10, 2017 21:16 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
ConversionCommon Stock | 35,461 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-031376 · doc4.xml · nonDerivative · entry 2 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 35,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse in the manager of Divo. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| May 10, 2017 Filed May 10, 2017 21:16 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
ConversionCommon Stock | 400,150 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-031376 · doc4.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,586,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date. Read SEC document |
| May 10, 2017 Filed May 10, 2017 17:13 UTC |
Daly TimothyVP, Finance & Corp. Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 46,510 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001209191-17-031370 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · VP, Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,510 Underlying: Common Stock · 46,510 shares Expires 2027-01-19 F1 · derivative.exercise_date: 100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.